Search Results - "Mule, JJ"
-
1
Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization
Published in Cancer research (Chicago, Ill.) (15-11-2001)“…There is considerable controversy as to whether necrotic (lysate) or apoptotic tumor cells serve as the superior source of multiple tumor-associated antigens…”
Get full text
Journal Article -
2
Tumor Lysate-Pulsed Dendritic Cells Can Elicit an Effective Antitumor Immune Response during Early Lymphoid Recovery
Published in Proceedings of the National Academy of Sciences - PNAS (22-01-2002)“…Dendritic cells (DC) can serve to immunize the newborn immune system to foreign antigen. In a lymphopenic environment, naive T cells undergoing…”
Get full text
Journal Article -
3
Murine Dendritic Cells Pulsed with Whole Tumor Lysates Mediate Potent Antitumor Immune Responses in vitro and in vivo
Published in Proceedings of the National Academy of Sciences - PNAS (04-08-1998)“…The highly efficient nature of dendritic cells (DC) as antigen-presenting cells raises the possibility of uncovering in tumor-bearing hosts very low levels of…”
Get full text
Journal Article -
4
Hematopoietic Potential of Cryopreserved and Ex Vivo Manipulated Umbilical Cord Blood Progenitor Cells Evaluated In Vitro and In Vivo
Published in Blood (15-02-1996)“…The hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood (UCB) samples was evaluated in vitro and in vivo. Phenotypic analysis…”
Get full text
Journal Article -
5
Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression
Published in Cancer research (Chicago, Ill.) (01-12-2001)“…Dendritic cells (DCs) have been shown to be a promising adjuvant for inducing immunity to cancer. We evaluated tumor lysate-pulsed DC in a Phase I trial of…”
Get full text
Journal Article -
6
Allogeneic and Autologous Melanoma Vaccines: Where Have We Been and Where Are We Going?
Published in Clinical cancer research (01-04-2006)“…The past three decades have seen substantial research on vaccines for the treatment of metastatic melanoma and the prevention of recurrence following…”
Get full text
Journal Article -
7
A Phase I Trial of Tumor Lysate-pulsed Dendritic Cells in the Treatment of Advanced Cancer
Published in Clinical cancer research (01-04-2002)“…Purpose: The objectives of this study were to assess the toxicity and immunologicalresponse induced by the intradermal (i.d) administration of tumor…”
Get full text
Journal Article -
8
Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis
Published in The Journal of clinical investigation (01-05-2001)“…Dendritic cells (DCs) are specialized antigen-presenting cells that migrate from the periphery to lymphoid tissues, where they activate and regulate T cells…”
Get full text
Journal Article -
9
The dynamics of the T-cell antitumor response: Chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally
Published in Cancer research (Chicago, Ill.) (15-12-2001)“…Direct administration of dendritic cells (DCs) genetically modified to express secondary lymphoid tissue chemokine (SLC) into growing B16 melanoma could result…”
Get full text
Journal Article -
10
Current developments of immunotherapy in the clinic
Published in Current opinion in immunology (01-04-2004)“…The clinical application of immunotherapy for cancer is rapidly moving forward in multiple areas, including the adoptive transfer of anti-tumor-reactive T…”
Get full text
Journal Article -
11
T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine : Augmentation of dendritic cell-based immunotherapy
Published in Cancer research (Chicago, Ill.) (01-03-2001)“…Secondary lymphoid tissue chemokine (SLC) is a CC chemokine that is selective in its recruitment of naive T cells and dendritic cells (DCs). In the lymph node,…”
Get full text
Journal Article -
12
Gene-modified dendritic cells for use in tumor vaccines
Published in Human gene therapy (10-04-2000)“…Dendritic cells (DCs) are potent antigen-presenting cells capable of priming activation of naive T cells. Because of their immunostimulatory capacity,…”
Get more information
Journal Article -
13
Enhancement of tumor lysate- and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein
Published in Cancer research (Chicago, Ill.) (15-03-2001)“…We have evaluated whether the addition of a foreign helper protein, keyhole limpet hemocyanin (KLH), can augment the efficacy of tumor lysate-pulsed dendritic…”
Get full text
Journal Article -
14
Systemic Administration of Interleukin 2 Enhances the Therapeutic Efficacy of Dendritic Cell-Based Tumor Vaccines
Published in Proceedings of the National Academy of Sciences - PNAS (02-03-1999)“…We have reported previously that murine bone marrow-derived dendritic cells (DC) pulsed with whole tumor lysates can mediate potent antitumor immune responses…”
Get full text
Journal Article -
15
Local administration of dendritic cells inhibits established breast tumor growth : Implications for apoptosis-inducing agents
Published in Cancer research (Chicago, Ill.) (2001)“…Dendritic cells (DCs) can efficiently acquire foreign antigen(s) from apoptotic cells and induce MHC class I-restricted, antigen-specific CTLs. An accumulation…”
Get full text
Journal Article -
16
Immune Evasion by Muscle-Specific Gene Expression in Dystrophic Muscle
Published in Molecular therapy (01-12-2001)“…Muscle tissue from Duchenne muscular dystrophy patients and the Dmdmdx/mdx (hereafter referred to as mdx) mouse is characterized by an abundance of necrotic…”
Get full text
Journal Article -
17
Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma model
Published in Journal of immunotherapy (1997) (01-07-2006)“…In this study, we examined the protective and therapeutic efficacy of the immunoadjuvant CpG in combination with dendritic cell (DC) immunotherapy in a murine…”
Get full text
Journal Article -
18
Inducible Expression of Macrophage Receptor Marco by Dendritic Cells Following Phagocytic Uptake of Dead Cells Uncovered by Oligonucleotide Arrays
Published in The Journal of immunology (1950) (15-09-2003)“…The efficient Ag presenting and immunostimulatory capacity of dendritic cells (DCs) has led to the use of tumor Ag-pulsed DCs in treatment regimens for cancer…”
Get full text
Journal Article -
19
Experimental and clinical studies of cytokine gene-modified tumor cells
Published in Human gene therapy (01-02-1994)“…Cytokines are key modulators of host immune and inflammatory responses. The expression of cytokine genes by tumor cells as a result of gene transfer has…”
Get more information
Journal Article -
20
Identification of human cancers deficient in antigen processing
Published in The Journal of experimental medicine (01-02-1993)“…Intracellular antigens must be processed before presentation to CD8+ T cells by major histocompatibility complex (MHC) class I molecules. Using a recombinant…”
Get full text
Journal Article